These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6898782)

  • 21. Amantadine in Parkinsonism. An extended prospective trial.
    Rao NS; Pearce J
    Practitioner; 1971 Feb; 206(232):241-5. PubMed ID: 4928964
    [No Abstract]   [Full Text] [Related]  

  • 22. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract]   [Full Text] [Related]  

  • 23. Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
    Rajput A; Kishore A; Snow B; Bolton CF; Rajput AH
    Mov Disord; 1997 May; 12(3):453-6. PubMed ID: 9159748
    [No Abstract]   [Full Text] [Related]  

  • 24. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment with midantan of patients with parkinsonism].
    Kadykov AS
    Sov Med; 1973 Sep; 36(9):143. PubMed ID: 4756486
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of Parkinson's syndrome].
    Fortschr Med; 1982 Jun; 100(24):1172. PubMed ID: 7106681
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment options for early Parkinson's disease.
    Stacy M; Brownlee HJ
    Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of amantadine on some psychomotor performances in Parkinsonism. A double blind study.
    Laitinen LV; Vilkki J
    Ann Clin Res; 1971 Aug; 3(4):207-11. PubMed ID: 4937341
    [No Abstract]   [Full Text] [Related]  

  • 29. Hereditary spastic paraplegia associated with dopa-responsive parkinsonism.
    Micheli F; Cersósimo MG; Zúñiga Ramírez C
    Mov Disord; 2006 May; 21(5):716-7. PubMed ID: 16463348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levodopa-responsive parkinsonism associated with hydrocephalus.
    Kim MJ; Chung SJ; Sung YH; Lee MC; Im JH
    Mov Disord; 2006 Aug; 21(8):1279-81. PubMed ID: 16639728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis.
    Jankovic J; Rajput AH; Golbe LI; Goodman JC
    Mov Disord; 1993 Oct; 8(4):525-32. PubMed ID: 8232366
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of parkinsonism.
    Selby G
    Drugs; 1976; 11(1):61-70. PubMed ID: 770132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease].
    Cersósimo MG; Scorticati MC; Micheli FE
    Medicina (B Aires); 2000; 60(3):321-5. PubMed ID: 11050808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism.
    Albanese A; Colosimo C; Lees AJ; Tonali P
    Adv Neurol; 1996; 69():393-8. PubMed ID: 8615156
    [No Abstract]   [Full Text] [Related]  

  • 35. CSF biopterin levels and clinical features of patients with juvenile parkinsonism.
    Furukawa Y; Nishi K; Kondo T; Mizuno Y; Narabayashi H
    Adv Neurol; 1993; 60():562-7. PubMed ID: 8420192
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of amantadine therapy on sleep spindles in patients with parkinsonism and comparative analysis of L-dopa effects].
    Puca FM; Pigneri MT
    Boll Soc Ital Biol Sper; 1972 May; 48(9):237-40. PubMed ID: 5070096
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison between the effects of L-dopa, prodipine and amantadine on the serum and CSF amino acid levels in Parkinson's disease (author's transl)].
    Gründig E; Gerstenbrand F
    Wien Klin Wochenschr; 1980 Dec; 92(24):868-71. PubMed ID: 7222702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases.
    Mark MH; Sage JI; Walters AS; Duvoisin RC; Miller DC
    Mov Disord; 1995 Jul; 10(4):450-4. PubMed ID: 7565825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of amantadine in the treatment of parkinsonism].
    D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A
    Minerva Med; 1971 Oct; 62(82):3952-4. PubMed ID: 5125049
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of amantadine in parkinsonism].
    Crudeli R; Candia O
    Minerva Med; 1971 Oct; 62(82):3963-4. PubMed ID: 5125053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.